Table S2. Detection of MET mutation in three types of samples from PTC patients.
| Sample | cfDNA | FFPE | gDNA | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Coverage | VarReads | VarFreq | Coverage | VarReads | VarFreq | Coverage | VarReads | VarFreq | |||
| 1 | 30,836 | 1,348 | 4.37% | 5,312 | 0 | 0 | 3,279 | 0 | 0 | ||
| 2 | 37,213 | 576 | 1.55% | 6,346 | 0 | 0 | 2,207 | 0 | 0 | ||
| 3 | 64,754 | 3,096 | 4.78% | 3,442 | 0 | 0 | 2,236 | 0 | 0 | ||
| 4 | 41,093 | 1,331 | 3.24% | 5,283 | 0 | 0 | 3,732 | 0 | 0 | ||
| 5 | 23,608 | 10,622 | 44.99% | 3,747 | 1,823 | 48.65% | 2,416 | 1,234 | 51.08% | ||
| 8 | 56,117 | 4,231 | 7.54% | 2,658 | 102 | 3.84% | 1,922 | 0 | 0 | ||
| 9 | 22,847 | 0 | 0 | 6,917 | 361 | 5.22% | 1,336 | 0 | 0 | ||
| 10 | 31,654 | 5,322 | 16.81% | 4,688 | 2,165 | 46.18% | 2,939 | 1,483 | 50.46% | ||
MET mutations were not detected in three types of samples from patients 5 and 7. PTC, papillary thyroid carcinoma; cfDNA, cell-free DNA; FFPE, formalin-fixed and paraffin-embedded.